Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage updates show minor UI and text changes with no impact on core study details (interventions, eligibility criteria, outcomes, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedNew sites have been added across the US, Canada, Belgium, France, Germany, Italy, the Netherlands, Poland, and the United Kingdom, and several locations were removed. The update changes where potential participants can enroll in the study.SummaryDifference2%

- Check26 days agoChange DetectedNo significant content changes were observed; updates are administrative and do not alter study design, eligibility, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedNon-substantive elements such as the last update timestamp appear refreshed; core study content and outcomes appear unchanged.SummaryDifference0.1%

- Check47 days agoChange Detected- The page includes an updated note that PubMed publications are automatically filled from PubMed and may not be about the study. - The revision version is updated to v3.3.2 (replacing the previous v3.2.0 wording).SummaryDifference0.1%

- Check54 days agoChange DetectedThe deletion removes a government funding status notice at the top of the page. All study content remains unchanged.SummaryDifference0.2%

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.